Doxazosin Mesylate

Doxazosin Mesylate

3.7 Moderate risk

Doxazosin Mesylate & Bladder transitional cell carcinoma

25.8%

of users reported Bladder transitional cell carcinoma

57.5%

also reported Hospitalization

100.0%

are women

Most common medical consequences

Hospitalization
57.5%
Severe reaction
42.5%

Have you experienced any negative side effects from this medication?

Doxazosin Mesylate: general information

Most common side effects (8)

Most commonly affected ages

60 - 69 years
37.0%
70 - 79 years
53.1%
80 - 89 years
10.0%
On this page
Doxazosin Mesylate & Bladder transitional cell carcinoma
Doxazosin Mesylate: general information